BNTX logo

BioNTech SE (BNTX) Revenue

Annual revenue:

$2.98B-$1.16B(-27.98%)
December 31, 2024

Summary

  • As of today (April 19, 2025), BNTX annual revenue is $2.98 billion, with the most recent change of -$1.16 billion (-27.98%) on December 31, 2024.
  • During the last 3 years, BNTX annual revenue has fallen by -$19.48 billion (-86.74%).
  • BNTX annual revenue is now -86.74% below its all-time high of $22.45 billion, reached on December 31, 2021.

Performance

BNTX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

Quarterly revenue:

$1.27B-$100.56M(-7.35%)
December 31, 2024

Summary

  • As of today (April 19, 2025), BNTX quarterly revenue is $1.27 billion, with the most recent change of -$100.56 million (-7.35%) on December 31, 2024.
  • Over the past year, BNTX quarterly revenue has dropped by -$100.56 million (-7.35%).
  • BNTX quarterly revenue is now -82.33% below its all-time high of $7.18 billion, reached on September 30, 2021.

Performance

BNTX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

TTM revenue:

$2.98B-$324.27M(-9.81%)
December 31, 2024

Summary

  • As of today (April 19, 2025), BNTX TTM revenue is $2.98 billion, with the most recent change of -$324.27 million (-9.81%) on December 31, 2024.
  • Over the past year, BNTX TTM revenue has dropped by -$324.27 million (-9.81%).
  • BNTX TTM revenue is now -88.99% below its all-time high of $27.06 billion, reached on March 31, 2022.

Performance

BNTX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXincome statement metrics

BNTX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-28.0%-7.3%-9.8%
3 y3 years-86.7%-63.6%-85.4%
5 y5 years+2349.2%+1507.0%+1498.4%

BNTX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-86.7%at low-82.3%+815.4%-89.0%+2.4%
5 y5-year-86.7%+2349.2%-82.3%+4049.7%-89.0%+2334.4%
alltimeall time-86.7%+4168.4%-82.3%+5248.4%-89.0%>+9999.0%

BioNTech SE Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$2.98B(-28.0%)
$1.27B(-7.3%)
$2.98B(-9.8%)
Sep 2024
-
$1.37B(+887.9%)
$3.30B(+13.5%)
Jun 2024
-
$138.58M(-32.0%)
$2.91B(-1.5%)
Mar 2024
-
$203.77M(-87.2%)
$2.95B(-28.3%)
Dec 2023
$4.13B(-77.4%)
$1.59B(+63.4%)
$4.12B(-40.3%)
Sep 2023
-
$974.79M(+433.1%)
$6.90B(-26.7%)
Jun 2023
-
$182.87M(-86.7%)
$9.42B(-25.5%)
Mar 2023
-
$1.37B(-68.6%)
$12.64B(-31.4%)
Dec 2022
$18.26B(-18.7%)
$4.37B(+25.5%)
$18.42B(-9.6%)
Sep 2022
-
$3.49B(+2.4%)
$20.37B(-15.3%)
Jun 2022
-
$3.40B(-52.4%)
$24.06B(-11.1%)
Mar 2022
-
$7.15B(+13.0%)
$27.06B(+20.9%)
Dec 2021
$22.45B
$6.33B(-11.8%)
$22.37B(+36.0%)
DateAnnualQuarterlyTTM
Sep 2021
-
$7.18B(+12.2%)
$16.46B(+75.9%)
Jun 2021
-
$6.40B(+159.2%)
$9.36B(+211.4%)
Mar 2021
-
$2.47B(+499.4%)
$3.01B(+429.8%)
Dec 2020
$550.80M(+353.0%)
$411.82M(+421.7%)
$567.25M(+204.3%)
Sep 2020
-
$78.93M(+71.9%)
$186.43M(+33.8%)
Jun 2020
-
$45.92M(+50.2%)
$139.37M(+13.9%)
Mar 2020
-
$30.57M(-1.4%)
$122.41M(+0.7%)
Dec 2019
$121.58M(-19.3%)
$31.00M(-2.7%)
$121.55M(-25.6%)
Sep 2019
-
$31.87M(+10.0%)
$163.31M(+5.3%)
Jun 2019
-
$28.97M(-2.5%)
$155.16M(+23.0%)
Mar 2019
-
$29.71M(-59.2%)
$126.19M(+30.8%)
Dec 2018
$150.64M(+115.9%)
$72.77M(+206.8%)
$96.49M(+306.8%)
Sep 2018
-
$23.72M
$23.72M
Dec 2017
$69.76M
-
-

FAQ

  • What is BioNTech SE annual revenue?
  • What is the all time high annual revenue for BioNTech SE?
  • What is BioNTech SE annual revenue year-on-year change?
  • What is BioNTech SE quarterly revenue?
  • What is the all time high quarterly revenue for BioNTech SE?
  • What is BioNTech SE quarterly revenue year-on-year change?
  • What is BioNTech SE TTM revenue?
  • What is the all time high TTM revenue for BioNTech SE?
  • What is BioNTech SE TTM revenue year-on-year change?

What is BioNTech SE annual revenue?

The current annual revenue of BNTX is $2.98B

What is the all time high annual revenue for BioNTech SE?

BioNTech SE all-time high annual revenue is $22.45B

What is BioNTech SE annual revenue year-on-year change?

Over the past year, BNTX annual revenue has changed by -$1.16B (-27.98%)

What is BioNTech SE quarterly revenue?

The current quarterly revenue of BNTX is $1.27B

What is the all time high quarterly revenue for BioNTech SE?

BioNTech SE all-time high quarterly revenue is $7.18B

What is BioNTech SE quarterly revenue year-on-year change?

Over the past year, BNTX quarterly revenue has changed by -$100.56M (-7.35%)

What is BioNTech SE TTM revenue?

The current TTM revenue of BNTX is $2.98B

What is the all time high TTM revenue for BioNTech SE?

BioNTech SE all-time high TTM revenue is $27.06B

What is BioNTech SE TTM revenue year-on-year change?

Over the past year, BNTX TTM revenue has changed by -$324.27M (-9.81%)
On this page